Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extravillous trophoblast cell lineage development is associated with active remodeling of the chromatin landscape. | Nat Commun | 2023 | 37563143 | PubTator, text mining | PubMed |
| C-Reactive Protein Signaling Pathways in Tumor Progression. | Biomol Ther (Seoul) | 2023 | 37562952 | PubTator, text mining | PubMed |
| miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets. | J Cell Mol Med | 2023 | 37555915 | PubTator, text mining | PubMed |
| The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. | Oncoimmunology | 2023 | 37554309 | PubTator, text mining | PubMed |
| Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. | Theranostics | 2023 | 37554269 | PubTator, text mining | PubMed |
| CircUSP48 promotes malignant behavior by regulating CYR61 via miR-365 in osteosarcoma. | Funct Integr Genomics | 2023 | 37553503 | PubTator, text mining | PubMed |
| Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer. | Oncol Res | 2023 | 37547760 | PubTator, text mining | PubMed |
| Corrigendum: Serum CYR61 is associated with airway inflammation and is a potential biomarker for severity in chronic obstructive pulmonary disease. | Front Med (Lausanne) | 2023 | 37547608 | PubTator, text mining | PubMed |
| TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma. | Cancer Rep (Hoboken) | 2023 | 37539777 | PubTator, text mining | PubMed |
| Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. | Front Immunol | 2023 | 37539053 | PubTator, text mining | PubMed |
| LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling. | Mol Cancer | 2023 | 37537569 | PubTator, text mining | PubMed |
| PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. | Sci Adv | 2023 | 37531433 | PubTator, text mining | PubMed |
| Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis. | Infect Immun | 2023 | 37530530 | PubTator, text mining | PubMed |
| Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways. | Indian J Ophthalmol | 2023 | 37530283 | PubTator, text mining | PubMed |
| WWC1/2 regulate spinogenesis and cognition in mice by stabilizing AMOT. | Cell Death Dis | 2023 | 37528078 | PubTator, text mining | PubMed |
| Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances. | Cureus | 2023 | 37525862 | PubTator, text mining | PubMed |
| Extracellular-Matrix Mechanics Regulate the Ocular Physiological and Pathological Activities. | J Ophthalmol | 2023 | 37521908 | PubTator, text mining | PubMed |
| Comparative Label-Free Liquid Chromatography-Mass Spectrometry Milk Proteomic Profiles Highlight Putative Differences between the Autochthon Teramana and Saanen Goat Breeds. | Animals (Basel) | 2023 | 37508040 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| Spontaneous urinary bladder regeneration after subtotal cystectomy increases YAP/WWTR1 signaling and downstream BDNF expression: Implications for smooth muscle injury responses. | PLoS One | 2023 | 37494380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=20